Saved in:
| Main Authors: | Kronthaler, David, Schwenkglenks, Matthias, Beuschlein, Felix, Held, Ulrike |
|---|---|
| Format: | Preprint |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2507.15685 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Edgington's Method for Random-Effects Meta-Analysis Part II: Prediction
by: Kronthaler, David, et al.
Published: (2025)
by: Kronthaler, David, et al.
Published: (2025)
Edgington's Method for Random-Effects Meta-Analysis Part I: Estimation
by: Kronthaler, David, et al.
Published: (2025)
by: Kronthaler, David, et al.
Published: (2025)
BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026)
by: Zhu, Di, et al.
Published: (2026)
Group Sequential Methods for the Win Ratio
by: Bergemann, Tracy, et al.
Published: (2026)
by: Bergemann, Tracy, et al.
Published: (2026)
Who's Winning? Clarifying Estimands Based on Win Statistics in Cluster Randomized Trials
by: Lee, Kenneth M., et al.
Published: (2026)
by: Lee, Kenneth M., et al.
Published: (2026)
Large-scale Data Integration using Matrix Denoising and Geometric Factor Matching
by: Held, Felix
Published: (2024)
by: Held, Felix
Published: (2024)
Restricted Win Probability with Bayesian Estimation for Implementing the Estimand Framework in Clinical Trials With a Time-to-Event Outcome
by: Leeberg, Michelle, et al.
Published: (2024)
by: Leeberg, Michelle, et al.
Published: (2024)
A Comparative Evaluation of Bayesian Model-Assisted Two-Stage Designs for Phase I/II Clinical Trials
by: Sun, Hao, et al.
Published: (2025)
by: Sun, Hao, et al.
Published: (2025)
Sequential Design with Derived Win Statistics
by: Zhang, Baoshan, et al.
Published: (2024)
by: Zhang, Baoshan, et al.
Published: (2024)
Is 1:1 Always Most Powerful? Why Careful Determination of Allocation Ratios Matters in Trial Design
by: Pin, Lukas, et al.
Published: (2025)
by: Pin, Lukas, et al.
Published: (2025)
Covariate Adjustment for the Win Odds: Application to Cardiovascular Outcomes Trials
by: Scheidegger, Cyrill, et al.
Published: (2025)
by: Scheidegger, Cyrill, et al.
Published: (2025)
Interpretational challenges of the Win Ratio in analyzing Hierarchical Composite Endpoints in Chronic Kidney Disease
by: Thomsen, Henrik F., et al.
Published: (2025)
by: Thomsen, Henrik F., et al.
Published: (2025)
An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties
by: Cui, Ying, et al.
Published: (2025)
by: Cui, Ying, et al.
Published: (2025)
Design of Bayesian Clinical Trials with Clustered Data
by: Hagar, Luke, et al.
Published: (2025)
by: Hagar, Luke, et al.
Published: (2025)
Rethinking the Win Ratio: A Causal Framework for Hierarchical Outcome Analysis
by: Even, Mathieu, et al.
Published: (2025)
by: Even, Mathieu, et al.
Published: (2025)
Bayes Factor Group Sequential Designs
by: Pawel, Samuel, et al.
Published: (2026)
by: Pawel, Samuel, et al.
Published: (2026)
A comparison of combined p-value functions for meta-analysis
by: Held, Leonhard, et al.
Published: (2024)
by: Held, Leonhard, et al.
Published: (2024)
Sparse and Orthogonal Low-rank Collective Matrix Factorization (solrCMF): Efficient data integration in flexible layouts
by: Held, Felix, et al.
Published: (2024)
by: Held, Felix, et al.
Published: (2024)
Estimation and Inference of the Win Ratio for Two Hierarchical Endpoints Subject to Censoring and Missing Data
by: Liu, Yi, et al.
Published: (2026)
by: Liu, Yi, et al.
Published: (2026)
ROMI: A Randomized Two-Stage Basket Trial Design to Optimize Doses for Multiple Indications
by: Wang, Shuqi, et al.
Published: (2024)
by: Wang, Shuqi, et al.
Published: (2024)
Incertus.jl -- The Julia Lego Blocks for Randomized Clinical Trial Designs
by: Ryeznik, Yevgen, et al.
Published: (2024)
by: Ryeznik, Yevgen, et al.
Published: (2024)
Robust Estimation of Moderated Causal Excursion Odds Ratio in Micro-Randomized Trials
by: Yu, Jiaxin, et al.
Published: (2025)
by: Yu, Jiaxin, et al.
Published: (2025)
Non-collapsibility and Built-in Selection Bias of Hazard Ratio in Randomized Controlled Trials
by: Bian, Helen, et al.
Published: (2024)
by: Bian, Helen, et al.
Published: (2024)
Biomarker-Guided Adaptive Enrichment Design with Threshold Detection for Clinical Trials with Time-to-Event Outcome
by: Hua, Kaiyuan, et al.
Published: (2024)
by: Hua, Kaiyuan, et al.
Published: (2024)
Some Bayesian Perspectives on Clinical Trials
by: Sokolova, Alexandra, et al.
Published: (2026)
by: Sokolova, Alexandra, et al.
Published: (2026)
Balancing Evidentiary Value and Sample Size of Adaptive Designs with Application to Animal Experiments
by: Held, Leonhard, et al.
Published: (2025)
by: Held, Leonhard, et al.
Published: (2025)
A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)
by: Komaki, Moka, et al.
Published: (2025)
A Class of Computational Methods to Reduce Selection Bias when Designing Phase 3 Clinical Trials
by: Zhan, Tianyu
Published: (2023)
by: Zhan, Tianyu
Published: (2023)
A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations
by: Pramanik, Paramahansa, et al.
Published: (2026)
by: Pramanik, Paramahansa, et al.
Published: (2026)
Optimal Designs for Two-Stage Inference
by: Stallrich, Jonathan W., et al.
Published: (2023)
by: Stallrich, Jonathan W., et al.
Published: (2023)
Integrating Prioritized and Non-Prioritized Structures in Win Statistics
by: Mou, Yunhan, et al.
Published: (2025)
by: Mou, Yunhan, et al.
Published: (2025)
Active-Controlled Trial Design for HIV Prevention Trials with a Counterfactual Placebo
by: Gao, Fei, et al.
Published: (2024)
by: Gao, Fei, et al.
Published: (2024)
Comparing HIV Vaccine Immunogenicity across Trials with Different Populations and Study Designs
by: Jin, Yutong, et al.
Published: (2024)
by: Jin, Yutong, et al.
Published: (2024)
Compatibility of Missing Data Handling Methods across the Stages of Producing Clinical Prediction Models
by: Tsvetanova, Antonia, et al.
Published: (2025)
by: Tsvetanova, Antonia, et al.
Published: (2025)
Stabilizing Thompson Sampling with Null Hypothesis Bayesian Response-Adaptive Randomization
by: Pawel, Samuel, et al.
Published: (2025)
by: Pawel, Samuel, et al.
Published: (2025)
Closed-Form Power and Sample Size Calculations for Bayes Factors
by: Pawel, Samuel, et al.
Published: (2024)
by: Pawel, Samuel, et al.
Published: (2024)
The replication of equivalence studies
by: Micheloud, Charlotte, et al.
Published: (2022)
by: Micheloud, Charlotte, et al.
Published: (2022)
Studying Optimal Designs for Multivariate Crossover Trials
by: Niphadkar, Shubham, et al.
Published: (2025)
by: Niphadkar, Shubham, et al.
Published: (2025)
TITE-Safety: Time-to-event Safety Monitoring for Clinical Trials
by: Martens, Michael J., et al.
Published: (2025)
by: Martens, Michael J., et al.
Published: (2025)
Leveraging External Controls in Clinical Trials: Estimands, Estimation, Assumptions
by: Liu, Bo, et al.
Published: (2025)
by: Liu, Bo, et al.
Published: (2025)
Similar Items
-
Edgington's Method for Random-Effects Meta-Analysis Part II: Prediction
by: Kronthaler, David, et al.
Published: (2025) -
Edgington's Method for Random-Effects Meta-Analysis Part I: Estimation
by: Kronthaler, David, et al.
Published: (2025) -
BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026) -
Group Sequential Methods for the Win Ratio
by: Bergemann, Tracy, et al.
Published: (2026) -
Who's Winning? Clarifying Estimands Based on Win Statistics in Cluster Randomized Trials
by: Lee, Kenneth M., et al.
Published: (2026)